Topic

Aetna (CVS Health)

A collection of 1351 issues

How to Get Prolastin-C (Alpha1-Proteinase Inhibitor) Covered by Aetna (CVS Health) in Georgia: PA Forms, Appeals Timeline & Scripts

Quick Answer: Prolastin-C Coverage by Aetna in Georgia Aetna requires prior authorization for Prolastin-C (alpha1-proteinase inhibitor) and classifies it as non-formulary on most 2024 commercial plans. To get coverage, you need: Pi*ZZ genotype confirmation, serum AAT level below 57 mg/dL, post-bronchodilator FEV₁ between 25-80% predicted, and a formulary
6 min read

How Long Does It Take to Get Xenpozyme (olipudase alfa-rpcp) Approved by Aetna (CVS Health) in Virginia? Complete Timeline & Appeals Guide

Quick Answer: Xenpozyme Approval Timeline in Virginia Aetna (CVS Health) typically takes 30-45 days for standard Xenpozyme prior authorization in Virginia, or 72 hours for expedited requests with documented medical urgency. The fastest path: have your specialist submit complete documentation (ASMD diagnosis with genetic confirmation, baseline organ assessments, and medical
5 min read

Renewing Emflaza (deflazacort) Approval with Aetna (CVS Health) in Washington: Timeline, Documentation, and Appeal Rights

Answer Box: Renewing Emflaza (deflazacort) with Aetna (CVS Health) in Washington Emflaza (deflazacort) renewals with Aetna (CVS Health) typically require annual reauthorization with documented positive clinical response. In Washington, submit renewal requests 30-60 days before expiration to avoid treatment gaps. Required documentation includes specialist consultation notes showing stabilized or improved
6 min read

How to Get Zolgensma (Onasemnogene Abeparvovec-xioi) Covered by Aetna CVS Health in Virginia: Complete Prior Authorization & Appeals Guide

Answer Box: Getting Zolgensma covered by Aetna CVS Health in Virginia requires meeting strict clinical criteria: age under 2 years, confirmed bi-allelic SMN1 mutations, anti-AAV9 antibody titer ≤1:50, and no advanced disease. Submit prior authorization through CVS Specialty (1-888-267-3277) with genetic testing, medical necessity letter, and steroid protocol. If
6 min read

How to Get Eloctate (efmoroctocog alfa) Covered by Aetna CVS Health in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Your Fastest Path to Eloctate Coverage Eloctate (efmoroctocog alfa) requires prior authorization from Aetna CVS Health in New York, with prescriptions limited to board-certified hematologists. Most Aetna plans consider Eloctate medically necessary for moderate-to-severe hemophilia A without step therapy requirements. If denied, you have 180 days for internal
5 min read

How to Get Gilenya (Fingolimod) Covered by Aetna CVS Health in Virginia: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Gilenya (Fingolimod) Covered by Aetna CVS Health in Virginia Aetna requires prior authorization for Gilenya (fingolimod) with approval valid for 12 months. Your neurologist must submit complete documentation including MS diagnosis, baseline EKG, ophthalmology exam, and prior therapy history at least 2 weeks before treatment. If denied,
5 min read

How to Get Enhertu (fam-trastuzumab deruxtecan-nxki) Covered by Aetna CVS Health in Washington: Complete PA Guide and Appeals Process

Answer Box: Getting Enhertu Covered in Washington Enhertu (fam-trastuzumab deruxtecan-nxki) requires prior authorization from Aetna CVS Health for all FDA-approved indications. Approval requires documented HER2 status (IHC 3+, ISH+, HER2-low 1-2+, or HER2-mutant), prior therapy failure, board-certified oncologist prescriber, and ILD monitoring plan. Submit via Aetna Enhertu Precertification Form GR-69531
5 min read